Abstract

BackgroundMonitoring of anti-drug antibodies (ATAS) or serum concentrations of adalimumab (ADA) in the treatment of inflammatory bowel disease (IBD) could provide an explanation for loss of efficacy and help optimise...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis
Stef P Menting ... Juul M P A Van Den Reek
Archives of dermatology | VOL. 150
Stef P Menting, et. al.Stef P Menting ... Juul M P A Van Den Reek
01 Feb 2014
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
Ingrid Ordás ... William J Sandborn
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | VOL. 10
Ingrid Ordás, et. al.Ingrid Ordás ... William J Sandborn
16 Jul 2012
Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study.
Mohammad Shehab ... Robert Battat
Frontiers in Medicine | VOL. 8
Mohammad Shehab, et. al.Mohammad Shehab ... Robert Battat
23 Dec 2021
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.
Murray L Barclay ... Michael Schultz
Internal medicine journal | VOL. 49
Murray L Barclay, et. al.Murray L Barclay ... Michael Schultz
01 Apr 2019
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
A single harmonised pharmacy process to improve clinical trial set-up times
Miriam Lettieri ... Beatriz Duran Jimenez
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Miriam Lettieri, et. al.Miriam Lettieri ... Beatriz Duran Jimenez
27 Jun 2024
Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region
Lisa Greve Routhe ... Anne Estrup Olesen
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lisa Greve Routhe, et. al.Lisa Greve Routhe ... Anne Estrup Olesen
26 Jun 2024
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients
Yan Yan ... Ji Wu
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Yan Yan, et. al.Yan Yan ... Ji Wu
19 Jun 2024
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK
Stephen Morris ... Andrew Salm
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Stephen Morris, et. al.Stephen Morris ... Andrew Salm
14 Jun 2024
View more papers